Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 522)
Posted On: 09/22/2020 5:53:22 PM
Post# of 72447
Posted By: immunodoc
Re: stocker11 #66573
I think the answer to this question has a few answers: 1) completely novel class with no precedent as opposed to the nucleoside analogs etc 2) High monetary stakes to big pharma ie even though the success of Rems is moderate at best, they have the power to continue to benefit 3) we are small....we need just stellar clinical results to overcome this.

Brilacidin makes so much sense from an immunologic and biochemical standpoint...in a few years it will be thought of as THE one that started a revolution. Degrado and others at UCSF and UW are on the cutting edge. Think about the discoverer of ivermectin. He won the Nobel. What will happen with Degrado and his former UPenn colleagues. He joined, he is excited. If he is excited, I am too













(11)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site